HMOX2 and cleft palate: In addition, we expect that increased levels of oxidative and inflammatory stress in HO-2 KO mice, and further increase of these stress levels, obtained by administration of HO-1 and HO-2 activity inhibitor SnMP at E11 in wt mice disrupts the migration of CNCCs to the orofacial region, increasing the risk of cleft palate.